The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
Abstract
A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P<0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism is also associated with left ventricular hypertrophy, diastolic dysfunction and heart failure, large artery stiffness, oxidative stress, widespread tissue inflammation and fibrosis, and increased resistance vessel remodeling compared with primary hypertension.291–293”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [291]
Citations
Cites
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e31823ac046 · Cited by 7,333
Universal Definition of Myocardial Infarction
Thygesen, K. A., Alpert, J. S., White, H. D., TASK FORCE MEMBERS: Chairpersons: Kristian Thygesen (Denmark), J. S. A. (., Biomarker Group: Allan S. Jaffe, C. (., ECG Group: Bernard Chaitman, C.-O. (., Imaging Group: Richard Underwood, C. (., Intervention Group: Jean-Pierre Bassand, C.-O. (., Mendis, S., Implementation Group: Lars C. Wallentin Coordinator (Sweden), F. F.-A. (., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.187397 · Cited by 4,422
Thygesen, K. A. (2007) · Circulation · Cited by 3,126
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Sokolow, M., & Lyon, T. P. (1949) · American Heart Journal · doi:10.1016/0002-8703(49)90562-1 · Cited by 1,990
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Self-citationSIMONE, G. D., Devereux, R. B., Daniels, S. R., Koren, M. J., Meyer, R. A., & Laragh, J. H. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00540-7 · Cited by 900
Oxford textbook of clinical nephrology
Cameron, S. M. (2013) · Oxford University Press eBooks · Cited by 717
Cited by
Sorted by citations
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Williams, T. A., Lenders, J. W. M., Mulatero, P., Burrello, J., Rottenkolber, M., Adolf, C., Satoh, F., Amar, L., Quinkler, M. O., Deinum, J., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30135-3 · Cited by 977
Self-citationPrevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice
Monticone, S., Burrello, J., Tizzani, D., Bertello, C., Viola, A., Buffolo, F., Gabetti, L., Mengozzi, G., Williams, T. A., Rabbia, F., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.01.052 · Cited by 888
Rossi, G. P., Auchus, R. J., Brown, M. J., Lenders, J. W. M., Naruse, M., Plouin, P., Satoh, F., & Young, W. F. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02097 · Cited by 615
Self-citationLong-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
Mulatero, P., Monticone, S., Bertello, C., Viola, A., Tizzani, D., Iannaccone, A., Crudo, V. L., Burrello, J., Milan, A., Rabbia, F., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2805 · Cited by 413
Diagnosis and treatment of primary aldosteronism: practical clinical perspectives
Young, W. F. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12831 · Cited by 333
Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma
Fernandes-Rosa, F. L., Williams, T. A., Riester, A., Steichen, O., Beuschlein, F., Boulkroun, S., Strom, T. M., Monticone, S., Amar, L., Meatchi, T., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03419 · Cited by 310
Self-citationVaidya, A., Mulatero, P., Baudrand, R. F., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 314
Naruse, M., Katabami, T., Shibata, H., Sone, M., Takahashi, K., Tanabe, A., Izawa, S., Ichijo, T., Otsuki, M., Omura, M., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0508 · Cited by 228
The Spectrum of Subclinical Primary Aldosteronism and Incident Hypertension: A Cohort Study
Brown, J. M., Robinson-Cohen, C., Luque-Fernandez, M. A., Allison, M. A., Baudrand, R., Ix, J. H., Kestenbaum, B., de Boer, I. H., & Vaidya, A. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0882 · Cited by 221
A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism
Fernandes-Rosa, F. L., Daniil, G., Orozco, I. J., Göppner, C., Zein, R. M. E., Jain, V., Boulkroun, S., Jeunemaı̂tre, X., Amar, L., Lefèbvre, H., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0053-8 · Cited by 216
Self-citationPrevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism
Ohno, Y., Sone, M., Inagaki, N., Yamasaki, T., Ogawa, O., Takeda, Y., Kurihara, I., Itoh, H., Umakoshi, H., Tsuiki, M., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10263 · Cited by 200
Primary aldosteronism — a multidimensional syndrome
Turcu, A. F., Yang, J., & Vaidya, A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00730-2 · Cited by 196
Age-Related Autonomous Aldosteronism
Nanba, K., Vaidya, A., Williams, G. H., Zheng, I., Else, T., & Rainey, W. E. (2017) · Circulation · doi:10.1161/circulationaha.117.028201 · Cited by 192
Guidelines for primary aldosteronism
Mulatero, P., Monticone, S., Burrello, J., Veglio, F., Williams, T. A., & Funder, J. W. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000001088 · Cited by 184
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol
Monticone, S., Viola, A., Rossato, D., Veglio, F., Reincke, M., Gómez-Sánchez, C. E., & Mulatero, P. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70069-5 · Cited by 180
Activating mutations in CTNNB1 in aldosterone producing adenomas
Åkerström, T., Maharjan, R., Willenberg, H. S., Cupisti, K., Ip, J. C. Y., Moser, A., Stalberg, P. L. H., Robinson, B. G., Iwen, K. A., Dralle, H., et al. (2016) · Scientific Reports · doi:10.1038/srep19546 · Cited by 178
Byrd, J. B., Turcu, A. F., & Auchus, R. J. (2018) · Circulation · doi:10.1161/circulationaha.118.033597 · Cited by 175
Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas
Williams, T. A., Peitzsch, M., Dietz, A., Dekkers, T., Bidlingmaier, M., Riester, A., Treitl, M., Rhayem, Y., Beuschlein, F., Lenders, J. W. M., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06186 · Cited by 167
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 162
Eisenhofer, G., Dekkers, T., Peitzsch, M., Dietz, A., Bidlingmaier, M., Treitl, M., Williams, T. A., Bornstein, S. R., Haase, M., Rump, L. C., et al. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.251199 · Cited by 159
Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma
Zheng, F.-F., Zhu, L.-M., Nie, A.-F., Li, X.-Y., Lin, J.-R., Zhang, K., Chen, J., Zhou, W.-L., Shen, Z.-J., Zhu, Y.-C., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.03346 · Cited by 151
Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations
Teo, A. E. D., Garg, S., Shaikh, L. H., Zhou, J., Karet, F. E., Gurnell, M., Happerfield, L. C., Marker, A. J., Bienz, M., Azizan, E. A. B. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504869 · Cited by 151
Pathogenesis and treatment of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0382-4 · Cited by 159
Burrello, J., Monticone, S., Losano, I., Cavaglià, G., Buffolo, F., Tetti, M., Covella, M., Rabbia, F., Veglio, F., Pasini, B., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.119.14063 · Cited by 147
Circadian Rhythm, Clock Genes, and Hypertension: Recent Advances in Hypertension
Costello, H. M., & Gumz, M. L. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.14519 · Cited by 147
Primary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 135
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism
Williams, T. A., Burrello, J., Sechi, L. A., Fardella, C., Matrozova, J., Adolf, C., Baudrand, R. F., Bernardi, S., Beuschlein, F., Catena, C., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11382 · Cited by 130
Satoh, F., Morimoto, R., Ono, Y., Iwakura, Y., Omata, K., Kudo, M., Takase, K., Seiji, K., Sasamoto, H., Honma, S., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04453 · Cited by 128
Williams, T. A., & Reincke, M. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0990 · Cited by 127
Systematic review of surgery and outcomes in patients with primary aldosteronism
Muth, A., Ragnarsson, Ó., Johannsson, G., & Wängberg, B. (2015) · British journal of surgery · doi:10.1002/bjs.9744 · Cited by 129
(2022) · PubMed Central · doi:10.6515/acs.202205_38(3).20220321a · Cited by 117
Ghorayeb, N. E., Mazzuco, T. L., Bourdeau, I., Mailhot, J., Zhu, P. S., Thérasse, É., & Lacroix, A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3915 · Cited by 110
Role of ACTH and Other Hormones in the Regulation of Aldosterone Production in Primary Aldosteronism
Ghorayeb, N. E., Bourdeau, I., & Lacroix, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00072 · Cited by 109
Parasiliti‐Caprino, M., Lopez, C., Prencipe, N., Lucatello, B. G., Settanni, F., Giraudo, G., Rossato, D., Mengozzi, G., Ghigo, E., Benso, A. S., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002441 · Cited by 105
Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism
Vorselaars, W. M. C. M., Nell, S., Postma, E. L., Zarnegar, R., Drake, F. T., Duh, Q., Talutis, S. D., McAneny, D. B., McManus, C. M., Lee, J. A., et al. (2019) · JAMA Surgery · doi:10.1001/jamasurg.2018.5842 · Cited by 101
Left ventricular remodeling and dysfunction in primary aldosteronism
Tsai, C., Pan, C., Chang, Y., Chen, Z., Wu, V., Hung, C., & Lin, Y. (2020) · Journal of Human Hypertension · doi:10.1038/s41371-020-00426-y · Cited by 100
Genetic Causes of Functional Adrenocortical Adenomas
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00189 · Cited by 107
Biomarkers to Guide Medical Therapy in Primary Aldosteronism
Hundemer, G. L., Leung, A. A. C., Kline, G. A., Brown, J. M., Turcu, A. F., & Vaidya, A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad024 · Cited by 92
Kitamoto, T., Suematsu, S., Matsuzawa, Y., Saito, J., Omura, M., & Nishikawa, T. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.24455 · Cited by 88
Seccia, T. M., Letizia, C., Muiesan, M. L., Lerco, S., Cesari, M., Bisogni, V., Petramala, L., Maiolino, G., Volpin, R., & Rossi, G. P. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002250 · Cited by 89
Diagnosis and management of primary aldosteronism
Vilela, L. A. P., & Almeida, M. Q. (2017) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000274 · Cited by 89
Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas
Åkerström, T., Willenberg, H. S., Cupisti, K., Ip, J. C. Y., Backman, S., Moser, A., Maharjan, R., Robinson, B. G., Iwen, K. A., Dralle, H., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0321 · Cited by 85
Burrello, J., Monticone, S., Buffolo, F., Lucchiari, M., Tetti, M., Rabbia, F., Mengozzi, G., Williams, T. A., Veglio, F., & Mulatero, P. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000880 · Cited by 84
Satoh, F., Morimoto, R., Seiji, K., Satani, N., Ota, H., Iwakura, Y., Ono, Y., Kudo, M., Nezu, M., Omata, K., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1161 · Cited by 80
Monticone, S., Satoh, F., Dietz, A., Goupil, R., Lang, K., Pizzolo, F., Gordon, R. D., Morimoto, R., Reincke, M., Stowasser, M., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06305 · Cited by 80
Ohya, Y., Arakawa, K., Arata, N., Arima, S., Arima, H., Asayama, K., Dohi, Y., Fukami, A., Furuhashi, M., Goto, K., et al. (2026) · Hypertension Research · doi:10.1038/s41440-025-02462-y · Cited by 91
Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism
Guo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. J., & Stowasser, M. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa001 · Cited by 74
Chen, S.-Y., Chen, J., Huang, W., Puar, T. H. K., Kek, P. C., Chueh, S., Lin, Y., Wu, V., & TAIPAI Study Group (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0375 · Cited by 74
Endothelial Dysfunction in Primary Aldosteronism
Chen, Z., Tsai, C., Pan, C., Chou, C., Liao, C., Hung, C., Wu, V., Lin, Y., & TAIPAI Study Group (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205214 · Cited by 74
Marzano, L. A., Colussi, G., Sechi, L. A., & Catena, C. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu154 · Cited by 73
Manolopoulou, J., Fischer, E., Dietz, A., Diederich, S., Holmes, D. T., Junnila, R. K., Grimminger, P., Reincke, M., Morganti, A., & Bidlingmaier, M. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000727 · Cited by 72
Ong, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 78
Umakoshi, H., Ogasawara, T., Takeda, Y., Kurihara, I., Itoh, H., Katabami, T., Ichijo, T., Wada, N., Shibayama, Y., Yoshimoto, T., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13582 · Cited by 74
Development and validation of subtype prediction scores for the workup of primary aldosteronism
Kobayashi, H. H., Abe, M., Soma, M., Takeda, Y., Kurihara, I., Itoh, H., Umakoshi, H., Tsuiki, M., Katabami, T., Ichijo, T., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001855 · Cited by 69
Guo, Z., Poglitsch, M., McWhinney, B. C., Ungerer, J. P. J., Ahmed, A. H., Gordon, R. D., Wolley, M. J., & Stowasser, M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01041 · Cited by 70
An update on novel mechanisms of primary aldosteronism
Zennaro, M., Boulkroun, S., & Fernandes-Rosa, F. L. (2014) · Journal of Endocrinology · doi:10.1530/joe-14-0597 · Cited by 69
Vilela, L. A. P., Rassi-Cruz, M., Guimaraes, A. G., Moises, C., Freitas, T. C., Alencar, N., Petenuci, J., Goldbaum, T. S., Maciel, A. A. W., Pereira, M. A. A., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00531 · Cited by 69
Wannachalee, T., Zhao, L., Nanba, K., Nanba, A. T., Shields, J. J., Rainey, W. E., Auchus, R. J., & Turcu, A. F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01182 · Cited by 70
Katabami, T., Fukuda, H., Tsukiyama, H., Tanaka, Y., Takeda, Y., Kurihara, I., Ito, H., Tsuiki, M., Ichijo, T., Wada, N., et al. (2019) · Journal of Hypertension · doi:10.1097/hjh.0000000000002070 · Cited by 68
Long-term blood pressure control in patients undergoing adrenalectomy for primary hyperaldosteronism
Wachtel, H., Cerullo, I., Bartlett, E. K., Kelz, R. R., Cohen, D. L., Karakousis, G. C., Roses, R. E., & Fraker, D. L. (2014) · Surgery · doi:10.1016/j.surg.2014.08.021 · Cited by 67
Adrenal vein sampling: technique and protocol, a systematic review
Quencer, K. B. (2021) · CVIR Endovascular · doi:10.1186/s42155-021-00220-y · Cited by 67
Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma
Fernandes-Rosa, F. L., Giscos-Douriez, I., Amar, L., Gómez-Sánchez, C. E., Méatchi, T., Boulkroun, S., & Zennaro, M. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05993 · Cited by 70
Self-citationThe Effect of Aldosterone on Cardiorenal and Metabolic Systems
Otsuka, H., Abe, M., & Kobayashi, H. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065370 · Cited by 72
Aging and Adrenal Aldosterone Production
Nanba, K., Vaidya, A., & Rainey, W. E. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10391 · Cited by 69
Bone and Mineral Metabolism in Patients with Primary Aldosteronism
Petramala, L., Zinnamosca, L., Settevendemmie, A., Marinelli, C., Nardi, M., Concistrè, A., Corpaci, F., Tonnarini, G., Toma, G. D., & Letizia, C. (2014) · International Journal of Endocrinology · doi:10.1155/2014/836529 · Cited by 65
Wu, V., Hu, Y.-H., Wu, C., Kao, C., Wang, C., Yang, W.-S., Lee, H., Chang, Y.-S., Lin, Y., Wang, S., et al. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.012 · Cited by 63
Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy
Espósito, D., Pasquali, D., & Johannsson, G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01928 · Cited by 61
Satoh, F., Ito, S., Itoh, H., Rakugi, H., Shibata, H., Ichihara, A., Omura, M., Takahashi, K., Okuda, Y., & Iijima, S. (2020) · Hypertension Research · doi:10.1038/s41440-020-00570-5 · Cited by 59
Murata, M., Kitamura, T., Tamada, D., Mukai, K., Kurebayashi, S., Yamamoto, T., Hashimoto, K., Hayashi, R., Kouhara, H., Takeiri, S., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001251 · Cited by 59
Turcu, A. F., Tezuka, Y., Lim, J. S., Salman, Z., Sehgal, K., Liu, H., Larose, S., Parksook, W. W., Williams, T. A., Cohen, D. L., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.123.21910 · Cited by 56
Primary Aldosteronism Diagnosis and Management
Hundemer, G. L., & Vaidya, A. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.08.002 · Cited by 59
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
Bioletto, F., Bollati, M., Lopez, C., Arata, S., Procopio, M., Ponzetto, F., Ghigo, E., Maccario, M., & Parasiliti‐Caprino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094803 · Cited by 55
Cardiovascular Risk in Primary Hyperaldosteronism
Warchoł-Celińska, E., Lenders, J. W. M., Januszewicz, A., & Prejbisz, A. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565124 · Cited by 53
Familial hyperaldosteronism type III
Monticone, S., Tetti, M., Burrello, J., Buffolo, F., Giovanni, R. D., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.34 · Cited by 52
Primary aldosteronism and salt
Funder, J. W. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1658-0 · Cited by 51
Diagnostic Value of ACTH Stimulation Test in Determining the Subtypes of Primary Aldosteronism
Jiang, Y., Zhang, C., Wang, W., Su, T., Zhou, W., Jiang, L., Zhu, W., Xie, J., & Ning, G. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3551 · Cited by 54
Management of hypertension in primary aldosteronism
Aronova, A., Fahey, T. J., & Zarnegar, R. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i5.227 · Cited by 51
Samnani, S., Cenzer, I., Kline, G. A., Lee, S. J., Hundemer, G. L., McClurg, C., Pasieka, J. L., Boscardin, W. J., Ronksley, P. E., & Leung, A. A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad654 · Cited by 50
Baron, S., Amar, L., Faucon, A., Blanchard, A., Baffalie, L., Faucard, C., Travers, S. A. A., Pagny, J.-Y., Azizi, M., & Houillier, P. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001735 · Cited by 50
Self-citationUnderstanding primary aldosteronism: impact of next generation sequencing and expression profiling
Monticone, S., Else, T., Mulatero, P., Williams, T. A., & Rainey, W. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.015 · Cited by 49
Rossi, G. P., Cesari, M., Letizia, C., Seccia, T. M., Cicala, M. V., Zinnamosca, L., Kuppusamy, M., Mareso, S., Sciomer, S., Iacobone, M., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000186 · Cited by 49
Chen, Y., Lin, Y.-H., Huang, W., Chueh, E., Chen, L., Yang, S., Lin, P., Lin, L., Lin, Y., Wu, V., et al. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00019 · Cited by 48
Aldosterone induces left ventricular subclinical systolic dysfunction
Chen, Z., Huang, K., Lee, J., Lin, L., Chen, C., Chang, Y., Liao, C., Wu, V., Hung, C.-S., & Lin, Y. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001534 · Cited by 48
Disordered CYP11B2 Expression in Primary Aldosteronism
Gómez-Sánchez, C. E., Kuppusamy, M., Reincke, M., & Williams, T. A. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-122238 · Cited by 48
Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling
Turcu, A. F., & Auchus, R. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa952 · Cited by 48
Adrenal Histopathology in Primary Aldosteronism
Gioco, F., Seccia, T. M., Gómez-Sánchez, E. P., Rossi, G. P., & Gómez-Sánchez, C. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05873 · Cited by 47
Long-term effect of specific treatment of primary aldosteronism on carotid intima–media thickness
Holaj, R., Rosa, J., Zelinka, T., Štrauch, B., Petrák, O., Indra, T., Krátká, Z., Michalský, D., Novák, K., Wichterle, D., et al. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000464 · Cited by 45
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Lin, X., Ullah, M. H. E., Xiong, W., Xu, F., Shan, S., Lei, L.-M., Yuan, L., & Liu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.798364 · Cited by 45
Prevalence and Risk Factors for Secondary Hypertension in Young Adults
de Fréminville, J.-B., Gardini, M., Cremer, A., Camelli, S., Baron, S., Bobrie, G., Gosse, P., Boulestreau, R., Gebara, N., Doublet, J., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.22753 · Cited by 45
Self-citationThe influence of aging on the diagnosis of primary aldosteronism
Nakama, C., Kamide, K., Kawai, T., Hongyo, K., Ito, N., Onishi, M., Takeya, Y., Yamamoto, K. I., Sugimoto, K., & Rakugi, H. (2014) · Hypertension Research · doi:10.1038/hr.2014.129 · Cited by 44
Estrogen Signaling in the Adrenal Cortex
Caroccia, B., Seccia, T. M., Barton, M., & Rossi, G. P. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07660 · Cited by 44
Clinical Characteristics and Postoperative Outcomes of Primary Aldosteronism in the Elderly
Takeda, M., Yamamoto, K. I., Akasaka, H., Rakugi, H., Naruse, M., Takeda, Y., Kurihara, I., Itoh, H., Umakoshi, H., Tsuiki, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00059 · Cited by 44
Skov, J., Sundström, A., Ludvigsson, J. F., Kämpe, O., & Bensing, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02298 · Cited by 44
Cardiovascular risk in primary aldosteronism
Wu, X., Yu, J., & Tian, H. (2019) · Medicine · doi:10.1097/md.0000000000015985 · Cited by 44
Chang, Y., Liao, C., Tsai, C., Chen, C., Pan, C., Chen, Z., Chen, Y., Lin, L., Chang, Y., Wu, V., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013263 · Cited by 44
Meng, Z., Dai, Z., Huang, K., Xu, C., Zhang, Y.-G., Zheng, H., & Liu, T.-Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00121 · Cited by 44
Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans
Redheuil, A. B., Blanchard, A., Pereira, H., Raissouni, Z., Lorthioir, A., Soulat, G., Vargas‐Poussou, R., Amar, L., Paul, J., Helley, D., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.026 · Cited by 44
Self-citation
Metadata
- Authors
- Savard, S., Amar, L., Plouin, P.-F., & Steichen, O.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Venue
- Hypertension
- Published
- 2013-08
- Volume
- 62
- Issue
- 2
- Pages
- 331-336
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2168924012
- Cited by
- 505
- References
- 50
- Citations by year
- 2026: 24 · 2025: 34 · 2024: 37 · 2023: 39 · 2022: 48 · 2021: 46 · 2020: 41 · 2019: 43 · 2018: 38 · 2017: 47 · 2016: 32 · 2015: 37 · 2014: 29 · 2013: 10
- FWCI
- 28.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Keywords
- primary aldosteronism, cardiovascular complications, essential hypertension, left ventricular hypertrophy, coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, aldosterone-renin ratio, serum potassium, plasma aldosterone, target organ damage
- MeSH terms
- Adult, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
